A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The goal of this study is to understand whether CRB-701, a targeted form of chemotherapy called an anti-body drug conjugate, will work as a treatment for oropharyngeal (throat, tonsil) cancer. In patients who have already received platinum based chemotherapy or immunotherapy (using a check-point inhibitor) It will also learn about the safety of the drug and measure quality of life. The main questions it asks are: * What proportion of participants respond to CRB-701 measured using scans (CT or MRI) * What medical problems do participants experience when taking CRB-701. Researchers will compare CRB-701 with standard of care medicines (drugs that are normally used this disease). Participants will: * Attend clinic every three weeks to receive infusions of CRB-701 or standard of care medicines until the cancer cannot be measured or is not controlled by the treatment they are receiving. * Have a CT or MRI every 6 weeks to measure the effect on their cancer * Complete questionnaires to assess their health status.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony rozpoznanie raka gardła lub migdałków z przerzutami lub nawrotem, który nie może być operacyjnie usunięty
- •Poprzednie leczenie chemioterapią na bazie platyny oraz immunoterapią (lub oba leczenia)
- •Ogólny stan zdrowia pozwalający na uczestnictwo w badaniu
- •Widoczne zmiany nowotworowe widoczne na badaniach obrazowych
- •Przewidywana długość życia co najmniej 12 tygodni
- •Pisemna zgoda na uczestnictwo w badaniu
✗ Disqualifies
- •Trwające poważne skutki uboczne z poprzedniego leczenia nowotworowego
- •Choroby rogówki oka
- •Utrwalona neuropatia obwodowa (uszkodzenie nerwów)
- •Inne poważne choroby lub problemy zdrowotne mogące wpływać na bezpieczeństwo
- •Ciąża lub karmienie piersią
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- October 8, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (111)
Clearview Cancer Institute
Huntsville, United States
The University of Arizona Cancer Center
Tucson, United States
City of Hope Comprehensive Cancer Center
Duarte, United States
University of California Los Angeles Westwood Cancer Center
Los Angeles, United States
Stanford Medicine - Cancer Center
Palo Alto, United States
Moores Cancer Center
San Diego, United States
UCSF Head and Neck Surgery Cancer Program
San Francisco, United States
UCHealth Cancer Care - Anschutz Medical Campus - University of Colorado
Colorado Springs, United States
Yale School of Medicine
Newhaven, United States
Medical Oncology Hematology Consultants
Newark, United States
Florida Cancer Specialists and Research Institute
Orlando, United States
Moffitt Cancer Center Magnolia Campus
Tampa, United States
University of Chicago
Chicago, United States
Iowa Health Care Holden Comprehensive Cancer Center
Iowa City, United States
University of Louisville Health
Louisville, United States
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
Baltimore, United States
Greater Baltimore Medical Center
Baltimore, United States
Dana Faber Cancer Institute
Boston, United States
Barbara Ann Karmanos Cancer Institute - Wayne State University
Detroit, United States
Mayo Clinic in Rochester
Rochester, United States
Washington University in St. Louis
St Louis, United States
Nebraska Cancer Specialists - Methodist Estabrook Cancer Center
Omaha, United States
NYU Langone Health Perlmutter Cancer Center
New York, United States
Memorial Sloan Kettering
New York, United States
Gabrail Cancer Center and Research Center
Canton, United States
Cleveland Clinic Main Campus
Cleveland, United States
The Ohio State University Comprehensive Cancer Center The Arthur G.James
Columbus, United States
Penn-Medicine - Abramson Cancer Center University of Pennsylvania
Philadelphia, United States
Fox Chase Cancer Center
Philadelphia, United States
MUSC Hollings Cancer Center
Charleston, United States
Prisma Health Cancer Institute Multidisciplinary Center
Greenville, United States
Tennessee Cancer Specialists
Knoxville, United States
Vanderbilt-Ingram Cancer Center
Nashville, United States
Texas Oncology
Austin, United States
Texas Oncology
Dallas, United States
UVA Health - Emily Couric Clinical Cancer Center
Charlottesville, United States
Fred Hutchinson Cancer Center Clinical - Seattle Cancer Care Alliance
Seattle, United States
Northwest Cancer Center
Vancouver, United States
University Hospital Vienna
Vienna, Austria
Ordensklinikum Linz Barmherzige Schwestern
Linz, Austria
University Hospital Vienna
Vienna, Austria
Universitair Ziekenhuis Antwerpen (UZA)
Edegem, Belgium
UZ Gent
Ghent, Belgium
UZ Leuven Gasthuisberg Campus
Leuven, Belgium
Vitaz - Sint-Niklaas Moerland
Sint-Niklaas, Belgium
Cliniques Universitaires Saint-Luc - Centre du Cancer
Woluwe-Saint-Lambert, Belgium
Cross Cancer Institute
Edmonton, Canada
Verspeeten Family Cancer Centre
London, Canada
Jewish General Hospital
Montreal, Canada
The Ottawa Hospital Cancer Centre
Ottawa, Canada
Allan Blair Cancer Centre
Regina, Canada
Institution: Institut de Cancerologie de Ouest (ICO) - Saint-Herblain
Saint-Herblain, France
ICM - Institut du Cancer de Montpellier
Montpellier, France
Institut Curie
Paris, France
Centre Hospitalier Universitaire (CHU) de Bordeaux - Hôpital Saint-André
Bordeaux, France
Centre Georges François Leclerc
Dijon, France
UNICANCER-Centre Leon-Berard (CLB)
Lyon, France
Hopitaux de Marseille AP-HM - Hopital de La Timone
Marseille, France
Universitätsklinikum Köln - Klinik und Poliklinik für Hals-, Nasen- und Ohrenheilkunde
Cologne, Germany
Universitaetsklinikum Leipzig
Leipzig, Germany
Universitaetsklinikum Muenster (UKM) - Klinik fuer Hals, Nasen und Ohrenheilkunde
Münster, Germany
Semmelweis Egyetem
Budapest, Hungary
Országos Onkológiai Intézet (National Institute of Oncology)
Budapest, Hungary
Debreceni Egyetem KLINIKAI KÖZPONT
Debrecen, Hungary
Semmelweis Egyetem
Szolnok, Hungary
Ospedali riuniti di Ancona - Clinica di Oncologia Medica
Ancona, Italy
Fondazione IRCCS - Istituto Nazionale dei Tumori
Milan, Italy
Azienda Ospedaliero-Universitaria di Modena-Policlinico di Modena
Modena, Italy
Azienda Ospedaliero Universitaria Pisana - Stabilimento di Santa Chiara
Pisa, Italy
Prato Santo Stefano
Prato, Italy
Gruppo Humanitas Humanitas Research Hospital Rozzano Cancer Center
Rozzano, Italy
Azienda Ospedaliera Universitaria Integrata Verona (AOUI) - Ospedale Borgo Trento
Verona, Italy
Instituto Português de Oncologia de Lisboa Francisco Gentil, EPE (IPO-Lisboa))
Lisbon, Portugal
Centro Hospitalar Universitario de Sao Joao
Lisbon, Portugal
Centro Hospitalar Universitario de Sao Joao
Porto, Portugal
Arensia Research Clinic Bucharest
Bucharest, Romania
Arensia Research Clinic Cluj-Napoca
Cluj-Napoca, Romania
Clinica de Oncologie Sf Nectarie
Craiova, Romania
Centrul de Oncologie-EUROCLINIC
Iași, Romania
OncoHelp - Ambulator OncoMed
Timișoara, Romania
Kosin University Gospel Hospital
Busan, South Korea
Chonbuk National University - Chonbuk National University Hospital - Jeonbuk Regional Cancer Center
Jeonju, South Korea
CHA University - CHA Bundang Medical Center (Bundang CHA General Hospital)
Seongnam, South Korea
Seoul National University Bundang Hospital - Comprehensive Cancer Center
Seongnam-si, South Korea
Severance Hospital - Yonsei Cancer Center
Seoul, South Korea
Korea University Guro Hospital
Seoul, South Korea
Ajou University Hospital
Suwon, South Korea
Pusan National University Yangsan Hospital - Oncology/Hematology Clinic
Yangsan, South Korea
Vall d'Hebron Institute of Oncology (VHIO)
Barcelona, Spain
Hospital Clinic Barcelona
Barcelona, Spain
Institut Catala d'Oncologia (ICO) - Hospital Duran i Reynals
Barcelona, Spain
Hospital Universitario Fundacion Jimenez Diaz
Madrid, Spain
Institut Català D'oncologia Girona - Hospital Josep Trueta
Girona, Spain
Hospital Universitario Virgen del Rocio (HUVR)
Seville, Spain
Hospital Universitario La Fe
Valencia, Spain
Hospital Universitario Miguel Servet (HUMS)
Zaragoza, Spain
Kaohsiung Medical University Chung-Ho Memorial Hospital - Cancer Center
Kaohsiung City, Taiwan
Chang Gung Memorial Hospital (CGMH)-Kaohsiung Branch
Kaohsiung City, Taiwan
China Medical University Hospital
Taichung, Taiwan
Taichung Veterans General Hospital (VGHTC)
Taichung, Taiwan
Chi Mei Hospital, Liouying
Tainan, Taiwan
Taipei Veterans General Hospital (VGH)
Taipei, Taiwan
Barts Health NHS Trust
London, United Kingdom
The Royal Marsden
Sutton, United Kingdom
University Hospitals Birmingham -Queen Elizabeth Hospital Birmingham
Birmingham, United Kingdom
Cambridge University Hospitals
Cambridge, United Kingdom
Cancer Research UK Scotland Institute (Formerly the Cancer Research UK Beatson Institute)
Glasgow, United Kingdom
The Clatterbridge Cancer Centre
Liverpool, United Kingdom
The Royal Marsden
London, United Kingdom
The Christie Hospital
Manchester, United Kingdom
Nottingham City Hospital
Nottingham, United Kingdom
Trial contact
Clinical Study Coordinator
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/9/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.